April 7 (Reuters) - Anatara Lifesciences Ltd (ANR) :
- CONTINUE TO ADVANCE LICENSING TALKS WITH POTENTIAL ANIMAL HEALTH PARTNERS FOR CORE ANIMAL ASSET, DETACH
- AT CURRENT TIME, ANTICIPATES DELAY, TO SECOND HALF OF 2020, FOR COMMENCEMENT OF ITS CLINICAL TRIAL IN IRRITABLE BOWEL SYNDROME
- DO NOT ANTICIPATE A MATERIAL DELAY OF MEETING PARTNERING MILESTONE FOR CORE ANIMAL ASSET DUE TO COVID-19
- AIM OF MEETING PARTNERING MILESTONE OF END Q2 FOR CORE ANIMAL ASSET, DETACH
April 7 (Reuters) - Anatara Lifesciences Ltd (ANR) : CONTINUE...
Add to My Watchlist
What is My Watchlist?